1-4 of 4
Roger E. G. Schutgens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Minke A. E. Rab, Jennifer Bos, Brigitte A. van Oirschot, Stephanie van Straaten, Penelope A. Kosinski, Victor Chubukov, Hyeryun Kim, Heidi Mangus, Roger E. G. Schutgens, Gerard Pasterkamp, Lenny Dang, Charles Kung, Eduard J. van Beers, Richard van Wijk
Journal: Blood
Blood (2021) 137 (21): 2997–3001.
https://doi.org/10.1182/blood.2020008635
Published: 2021
Includes: Supplemental data
Journal Articles

New concepts for anticoagulant therapy in persons with hemophilia

Roger E. G. Schutgens, Jeroen F. van der Heijden, Eveline P. Mauser-Bunschoten, Pier M. Mannucci
Journal: Blood
Blood (2016) 128 (20): 2471–2474.
https://doi.org/10.1182/blood-2016-07-727032
Published: 2016
Journal Articles

IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy

Lize F. D. van Vulpen, Roger E. G. Schutgens, Katja Coeleveld, Els C. Alsema, Goris Roosendaal, Simon C. Mastbergen, Floris P. J. G. Lafeber
Journal: Blood
Blood (2015) 126 (19): 2239–2246.
https://doi.org/10.1182/blood-2015-03-635524
Published: 2015
Journal Articles

How I treat age-related morbidities in elderly persons with hemophilia

Pier M. Mannucci, Roger E. G. Schutgens, Elena Santagostino, Evelien P. Mauser-Bunschoten
Journal: Blood
Blood (2009) 114 (26): 5256–5263.
https://doi.org/10.1182/blood-2009-07-215665
Published: 2009